The Biohaven 202 Study is a 12-month migraine study of an investigational medication that is taken as needed for migraine headache in the form of a nasal spray.
You may qualify to participate if you:
- Are at least 18 years of age
- Have a history of migraine for 12 months or longer
- Have 2 to 8 migraine headaches per month
If you are interested, please contact us and we will perform a quick pre-screen over the phone, to see if you qualify for this study.
For more information, call or text Dr. Counihan at 617-875-0962. Please include your contact information and the best time of day to contact you.